[Federal Register Volume 87, Number 225 (Wednesday, November 23, 2022)]
[Notices]
[Pages 71684-71686]
[FR Doc No: 2022-25545]

-----------------------------------------------------------------------

DEPARTMENT OF LABOR

Occupational Safety and Health Administration

[Docket No. OSHA-2006-0028]

Eurofins Electrical and Electronic Testing NA, Inc. a/k/a MET
Laboratories, Inc.: Application for Expansion of Recognition

AGENCY: Occupational Safety and Health Administration (OSHA), Labor.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In this notice, OSHA announces the application of Eurofins
Electrical and Electronic Testing NA, Inc. a/k/a MET Laboratories,
Inc., for expansion of the recognition as a Nationally Recognized
Testing Laboratory (NRTL) and presents the agency's preliminary finding
to grant the application.

DATES: Submit comments, information, and documents in response to this
notice, or requests for an extension of time to make a submission, on
or before December 8, 2022.

ADDRESSES: Submit comments by any of the following methods:
    Electronically: Submit comments and attachments electronically at
http://www.regulations.gov, which is the Federal eRulemaking Portal.
Follow the instructions online for making electronic submissions.
    Docket: To read or download comments or other material in the
docket, go to http://www.regulations.gov. All documents in the docket
(including this Federal Register notice) are listed in the http://www.regulations.gov index; however, some information (e.g., copyrighted
material) is not publicly available to read or download through the
website.

All submissions, including copyrighted material, are available for
inspection through the OSHA Docket Office. Contact the OSHA Docket
Office at<PHONE_NUMBER> (TTY<PHONE_NUMBER>) for assistance in
locating docket submissions.
    Instructions: All submissions must include the agency name and the
OSHA docket number (OSHA-2006-0028). OSHA places comments and other
materials, including any personal information, in the public docket
without revision, and these materials will be available online at
http://www.regulations.gov. Therefore, the agency cautions commenters
about submitting statements they do not want made available to the
public, or submitting comments that contain personal information
(either about themselves or others) such as Social Security numbers,
birth dates, and medical data.
    Extension of comment period: Submit requests for an extension of
the comment period on or before December 8, 2022 to the Office of
Technical Programs and Coordination Activities, Directorate of
Technical Support and Emergency Management, Occupational Safety and
Health Administration, U.S. Department of Labor, 200 Constitution
Avenue NW, Room N-3653, Washington, DC 20210, or by fax to (202) 693-
1644.

FOR FURTHER INFORMATION CONTACT: Information regarding this notice is
available from the following sources:
    Press inquiries: Contact Mr. Frank Meilinger, Director, OSHA Office
of Communications, phone:<PHONE_NUMBER> or email:
[email protected].
    General and technical information: Contact Mr. Kevin Robinson,
Director, Office of Technical Programs and Coordination Activities,
Directorate of Technical Support and Emergency Management, Occupational
Safety and Health Administration, phone:<PHONE_NUMBER> or email:
[email protected].

SUPPLEMENTARY INFORMATION:

I. Notice of the Application for Expansion

    OSHA is providing notice that Eurofins Electrical and Electronic
Testing NA, Inc. a/k/a MET Laboratories, Inc. (MET), is applying for
expansion of the current recognition as a NRTL. MET requests the
addition of two test standards to the NRTL scope of recognition.
    OSHA recognition of a NRTL signifies that the organization meets
the requirements specified in 29 CFR 1910.7. Recognition is an
acknowledgment that the organization can perform independent safety
testing and certification of the specific products covered within the
scope of recognition. Each NRTL's scope of recognition includes: (1)
the type of products the NRTL may test, with each type specified by the
applicable test standard; and (2) the recognized site(s) that has/have
the technical capability to perform the product-testing and product-
certification activities for test standards within the NRTL's scope.
Recognition is not a delegation or grant of government authority;
however, recognition enables employers to use products approved by the
NRTL to meet OSHA standards that require product testing and
certification.
    The agency processes applications by a NRTL for initial recognition
and for an expansion or renewal of this recognition, following
requirements in Appendix A to 29 CFR 1910.7. This appendix requires
that the agency publish two notices in the Federal Register in
processing an application. In the first notice, OSHA announces the
application and provides a preliminary finding. In the second notice,
the agency provides a final decision on the application. These notices
set forth the NRTL's scope of recognition or modifications of that
scope. OSHA maintains an informational web page for each NRTL,
including MET, which details the NRTL's scope of recognition. These
pages are available from the OSHA website at http://www.osha.gov/dts/otpca/nrtl/index.html.
    MET currently has one facility (site) recognized by OSHA for
product testing and certification, with the headquarters located at:
MET Laboratories, Inc., 914 West Patapsco Avenue, Baltimore, Maryland
21230. A complete list of MET's scope of recognition is available at
https://www.osha.gov/nationally-recognized-testing-laboratory-program/met.

II. General Background on the Application

    MET submitted one application, dated September 3, 2021 (OSHA-2006-
0028-0092), to expand the recognition to include two additional test
standards. OSHA staff performed a detailed analysis of the application
packet and reviewed other pertinent information. OSHA did not perform
any on-site reviews in relation to this application.
    Table 1, below, lists the appropriate test standards found in MET's
application for expansion for testing and certification of products
under the NRTL Program.

Table 1--Proposed Appropriate Test Standards for Inclusion in MET's NRTL
                          Scope of Recognition
------------------------------------------------------------------------
           Test standards                     Test standard title
------------------------------------------------------------------------
UL 698A.............................  Standard for Industrial Control
                                       Panels Related to Hazardous
                                       (Classified) Locations.
UL 60079-31.........................  Standard for Safety Explosive
                                       Atmospheres--Part 31: Equipment
                                       Dust Ignition Protection by
                                       Enclosure ``t''.
------------------------------------------------------------------------

III. Preliminary Findings on the Application

    MET submitted an acceptable application for expansion of the scope
of recognition. OSHA's review of the application file, and pertinent
documentation, indicate that MET has met the requirements prescribed by
29 CFR 1910.7 for expanding the recognition to include the addition of
the two test standards for NRTL testing and certification listed in
Table 1. This preliminary finding does not constitute an interim or
temporary approval of MET's application.
    OSHA seeks comment on this preliminary determination.

IV. Public Participation

    OSHA welcomes public comment as to whether MET meets the
requirements of 29 CFR 1910.7 for expansion of recognition as a NRTL.
Comments should consist of pertinent written documents and exhibits.
    Commenters needing more time to comment must submit a request in
writing, stating the reasons for the request by the due date for
comments. OSHA will limit any extension to 10 days unless the requester
justifies a longer time period. OSHA may deny a request for an
extension if it is not adequately justified.
    To review copies of the exhibits identified in this notice, as well
as comments submitted to the docket, contact the Docket Office,
Occupational Safety and Health Administration, U.S. Department of
Labor. These materials also are generally available online at

https://www.regulations.gov under Docket No. OSHA-2006-0028 (for
further information, see the ``Docket'' heading in the section of this
notice titled ADDRESSES).
    OSHA staff will review all comments to the docket submitted in a
timely manner. After addressing the issues raised by these comments,
staff will make a recommendation to the Assistant Secretary of Labor
for Occupational Safety and Health on whether to grant MET's
application for expansion of the scope of recognition. The Assistant
Secretary will make the final decision on granting the application. In
making this decision, the Assistant Secretary may undertake other
proceedings prescribed in Appendix A to 29 CFR 1910.7.
    OSHA will publish a public notice of the final decision in the
Federal Register.

V. Authority and Signature

    James S. Frederick, Deputy Assistant Secretary of Labor for
Occupational Safety and Health, authorized the preparation of this
notice. Accordingly, the agency is issuing this notice pursuant to 29
U.S.C. 657(g)(2), Secretary of Labor's Order No. 8-2020 (85 FR 58393,
Sept. 18, 2020), and 29 CFR 1910.7.

    Signed at Washington, DC, on November 17, 2022.
James S. Frederick,
Deputy Assistant Secretary of Labor for Occupational Safety and Health.
[FR Doc. 2022-25545 Filed 11-22-22; 8:45 am]
BILLING CODE 4510-26-P


[Federal Register: August 1, 2007 (Volume 72, Number 147)]
[Notices]
[Page 42159-42160]
[DOCID:fr01au07-124]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[Release No. 34-56139; File No. SR-CBOE-2007-86]

Self-Regulatory Organizations; Chicago Board Options Exchange,
Incorporated; Notice of Filing and Immediate Effectiveness of Proposed
Rule Change to Extend the Penny Pilot Program

July 26, 2007.
    Pursuant to section 19(b)(1) of the Securities Exchange Act of 1934
(``Act''),\1\ and Rule 19b-4 thereunder,\2\ notice is hereby given that
on July 24, 2007, the Chicago Board Options Exchange, Incorporated
(``CBOE'' or ``Exchange'') filed with the Securities and Exchange
Commission (``Commission'') the proposed rule change as described in
Items I and II below, which Items have been substantially prepared by
the CBOE. The Exchange filed the proposal as a ``non-controversial''
proposed rule change pursuant to section 19(b)(3)(A)(iii) of the Act
\3\ and Rule 19b-4(f)(6) thereunder,\4\ which rendered the proposal
effective upon filing with the Commission. The Commission is publishing
this notice to solicit comments on the proposed rule change from
interested persons.
---------------------------------------------------------------------------

    \1\ 15 U.S.C. 78s(b)(1).
    \2\ 17 CFR 240.19b-4.
    \3\ 15 U.S.C. 78s(b)(3)(A)(iii).
    \4\ 17 CFR 240.19b-4(f)(6).
---------------------------------------------------------------------------

I. Self-Regulatory Organization's Statement of the Terms of Substance
of the Proposed Rule Change

    The Exchange proposes to extend the Penny Pilot Program. The text
of the proposed rule change is available at CBOE, the Commission's
Public Reference Room, and http://www.cboe.com.

II. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change

    In its filing with the Commission, CBOE included statements
concerning the purpose of, and basis for, the proposed rule change and
discussed any comments it received on the proposed rule change. The
text of these statements may be examined at the places specified in
Item IV below. The Exchange has prepared summaries, set forth in
sections A, B, and C below, of the most significant aspects of such
statements.

A. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change

1. Purpose
    On January 23, 2007, the Commission approved CBOE's rule filing
(SR-CBOE-2006-92),\5\ which permits thirteen option classes to quote in
penny increments in connection with the implementation of an industry
wide, six month Penny Pilot Program.\6\ The Penny

Pilot Program is scheduled to expire on July 26, 2007. CBOE proposes to
extend the Penny Pilot Program in the thirteen option classes for an
additional two months, until September 27, 2007, while the Commisison
analyzes whether to expand the Pilot, and if so, by how much. CBOE
understands that all options exchanges are submitting similar rule
filings to extend the duration of the Penny Pilot Program until
September 27, 2007.
---------------------------------------------------------------------------

    \5\ See Securities Exchange Act Release No. 55154 (January 23,
2007), 72 FR 4743 (February 1, 2007) (SR-CBOE-2006-92).
    \6\ The Exchange acknowledged that the approval order permitted
quoting in penny increments in the Pilot classes. Telephone
conversation between Patrick Sexton, Associate General Counsel,
CBOE, Jennifer L. Colihan, Special Counsel, Division of Market
Regulation (``Division''), Commission, and Johnna B. Dumler, Special
Counsel, Division, Commission, on July 25, 2007.
---------------------------------------------------------------------------

2. Statutory Basis
    The Exchange believes that its proposal is consistent with section
6(b) of the Act \7\ in general, and furthers the objectives of section
6(b)(5) of the Act \8\ in particular, in that it is designed to promote
just and equitable principles of trade, to prevent fraudulent and
manipulative acts, and, in general, to protect investors and the public
interest.
---------------------------------------------------------------------------

    \7\ 15 U.S.C. 78f(b).
    \8\ 15 U.S.C. 78f(b)(5).
---------------------------------------------------------------------------

B. Self-Regulatory Organization's Statement on Burden on Competition

    The Exchange does not believe that the proposed rule change will
impose any burden on competition that is not necessary or appropriate
in furtherance of the purposes of the Act.

C. Self-Regulatory Organization's Statement on Comments on the Proposed
Rule Change Received From Members, Participants, or Others

    No written comments were either solicited or received by the
Exchange.

III. Date of Effectiveness of the Proposed Rule Change and Timing for
Commission Action

    The proposed rule change has become effective pursuant to section
19(b)(3)(A) of the Act \9\ and Rule 19b-4(f)(6) thereunder,\10\ because
the foregoing proposed rule does not: (i) Significantly affect the
protection of investors or the public interest; (ii) impose any
significant burden on competition; and (iii) become operative for 30
days from the date on which it was filed, or such shorter time as the
Commission may designate if consistent with the protection of investors
and the public interest.
---------------------------------------------------------------------------

    \9\ 15 U.S.C. 78s(b)(3)(A).
    \10\ 17 CFR 240.19b-4(f)(6).
---------------------------------------------------------------------------

    A proposed rule change filed under Rule 19b-4(f)(6) normally may
not become operative prior to 30 days after the date of filing.\11\
However, Rule 19b-4(f)(6)(iii) permits the Commission to designate a
shorter time if such action is consistent with the protection of
investors and the public interest.\12\ The Exchange has requested that
the Commission waive the 30-day operative delay. The Commission
believes that waiving the 30-day operative delay is consistent with the
protection of investors and the public interest because such waiver
will ensure continuity of the Exchange's rules and will allow the Penny
Pilot Program to remain in effect without interruption. For these
reasons, the Commission designates the proposal to be operative upon
filing with the Commission.\13\
---------------------------------------------------------------------------

    \11\ 17 CFR 240.19b-4(f)(6)(iii). In addition, Rule 19b-
4(f)(6)(iii) requires the self-regulatory organization to give the
Commission notice of its intent to file the proposed rule change,
along with a brief description and text of the proposed rule change,
at least five business days prior to the date of filing of the
proposed rule change, or such shorter time as designated by the
Commission. CBOE has satisfied the five-day pre-filing requirement.
    \12\ 17 CFR 240.19b-4(f)(6)(iii).
    \13\ For purposes only of waiving the 30-day operative delay,
the Commission has considered the proposed rule's impact on
efficiency, competition, and capital formation. 15 U.S.C. 78c(f).
---------------------------------------------------------------------------

    At any time within 60 days of the filing of the proposed rule
change, the Commission may summarily abrogate such rule change if it
appears to the Commission that such action is necessary or appropriate
in the public interest, for the protection of investors, or otherwise
in furtherance of the purposes of the Act.\14\
---------------------------------------------------------------------------

    \14\ See 15 U.S.C. 78s(b)(3)(C).
---------------------------------------------------------------------------

IV. Solicitation of Comments

    Interested persons are invited to submit written data, views, and
arguments concerning the foregoing, including whether the proposed rule
change is consistent with the Act. Comments may be submitted by any of
the following methods:

Electronic Comments

     Use the Commission's Internet comment form (http://www.sec.gov/rules/sro.shtml.
); or     Send an e-mail to<EMAIL_ADDRESS>Please include

File Number SR-CBOE-2007-86 on the subject line.

Paper Comments

     Send paper comments in triplicate to Nancy M. Morris,
Secretary, Securities and Exchange Commission, 100 F. Street, NE.,
Washington, DC 20549-1090.
    All submissions should refer to File Number SR-CBOE-2007-86. This
file number should be included on the subject line if e-mail is used.
To help the Commission process and review your comments more
efficiently, please use only one method. The Commission will post all
comments on the Commission's Internet Web site (http://www.sec.gov/rules/sro.shtml
). Copies of the submission, all subsequent amendments,

all written statements with respect to the proposed rule change that
are filed with the Commission, and all written communications relating
to the proposed rule change between the Commission and any person,
other than those that may be withheld from the public in accordance
with the provisions of 5 U.S.C. 552, will be available for inspection
and copying in the Commission's Public Reference Room, 100 F Street,
NE., Washington, DC 20549, on official business days between the hours
of 10 a.m. and 3 p.m. Copies of the filing also will be available for
inspection and copying at the principal office of the CBOE. All
comments received will be posted without change; the Commission does
not edit personal identifying information from submissions. You should
submit only information that you wish to make available publicly. All
submissions should refer to File Number SR-CBOE-2007-86 and should be
submitted on or before August 22, 2007.

    For the Commission, by the Division of Market Regulation,
pursuant to delegated authority.\15\
Florence E. Harmon,
Deputy Secretary.
---------------------------------------------------------------------------

    \15\ 17 CFR 200.30-3(a)(12).
---------------------------------------------------------------------------

[FR Doc. E7-14840 Filed 7-31-07; 8:45 am]

BILLING CODE 8010-01-P


TABLE 2 ANNUAL BURDEN OF REPORTING AND RECORDKEEPING REQUIREMENTS NEW SOURCE PERFORMANCE STANDARD ( NSPS) SUBPART TTT  PLASTIC PARTS FOR BUSINESS MACHINES REPORTING/ RECORDKEEPING REQUIREMENT Hours/ Occurence ( A) Occurences/

Year ( B) Hours/ Year ( C= A* B)

( C) Respondents/

Year ( D) Hours/ Year ( E= C* D)

( E) Costs/ Year ( F)

1. APPLICATIONS N/ A N/ A N/ A N/ A N/ A N/ A 2. SURVEY AND STUDIES N/ A N/ A N/ A N/ A N/ A N/ A 3. REPORTING REQUIREMENTS a. Read Instructions 1 1 1 1 1 $ 54.94 b. Required Activities Initial Performance Tests 3 1 3 1 3 $ 164.82 Demonstration of CMS N/ A N/ A N/ A N/ A N/ A N/ A Repeat of Performance Tests 3 0.2 0.6 1 0.6 $ 32.96 Method 24 Testing 90 0.04 3.6 1 3.6 $ 197.78 c. Create Information  Included in 3b

d. Gather Existing Information  Included in 3e

e. Write Report Notification of Construction/ Reconstruction 2 1 2 1 2 $ 109.88 Notification of Anticipated Startup 2 1 2 1 2 $ 109.88 Notification of Actual Startup 2 1 2 1 2 $ 109.88 Notification of Initial Performance Test 2 1 2 1 2 $ 109.88 Report of Performance Test 6 1 6 1 6 $ 329.64 Quarterly Report of Noncompliance 16 0.2 3.2 41 131.2 $ 7,208.13 Semiannual Report of Compliance 0.5 2 1 41 41 $ 2,252.54 4. RECORDKEEPING REQUIREMENTS a. Read Instructions  Included in 3a

b. Plan Activities  Included in 3b

c. Implement Activities  Included in 3b

d. Develop Record System 1 1 1 1 1 $ 54.94 e. Time to Enter Information Record of monthly performance tests 7 12 84 41 3444 $ 189,213.36 f. Train Personnel N/ A N/ A N/ A N/ A N/ A N/ A g. Audits N/ A N/ A N/ A N/ A N/ A N/ A TOTAL ANNUAL BURDEN 3639.4 $ 199,948.64 Assumptions Number of affected facilities ( per year) 41 Time required to read instructions ( hours) 1 Time required to complete performance test ( hours) 3 Rate of failed performance tests 20%

Number of new facilities ( per year) 1 It is assumed the EPA Reference Method 24 test performed on the coatings used by the respondents is generally done by the coatings manufacturers, who provide the test results to the respondents. It is further assumed that the coatings manufacturers routinely perform an EPA Method 24 analysis on their coatings as a quality control measure, so there will be no additional cost incurred by the coatings manufacturers.

It is assumed that 1% of all respondents must generate Method 24 data for a coating because they modify the coatings.

This situation is assumed to occur 4 times per year.

20% of all NSPS facilities report noncompliance each year.

Technical labor rate ( Bureau of Labor Statistics) $ 54.94


[Federal Register Volume 77, Number 64 (Tuesday, April 3, 2012)]
[Notices]
[Pages 20026-20030]
[FR Doc No: 2012-7908]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2012-D-0071]

Draft Guidance for Industry: Modified Risk Tobacco Product
Applications; Availability; Agency Information Collection Activities;
Proposed Collection; Comment Request

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing the
availability of a draft guidance for industry entitled ``Modified Risk
Tobacco Product Applications.'' The draft guidance provides information
about submitting applications for modified risk tobacco products under
the Federal Food, Drug, and Cosmetic Act (the FD&C Act). The draft
guidance describes the information that the FD&C Act requires you to
submit in your modified risk tobacco product application and the
scientific evidence FDA recommends you submit to support your
application. The draft guidance also permits the filing of a single
application for any modified risk tobacco product that is also a new
tobacco product under the FD&C Act.

DATES: Although you can submit written or electronic comments on this
guidance at any time (see 21 CFR 10.115(g)(5)), to ensure that the
Agency considers your comment on this draft guidance before it begins
work on the final version of the guidance, submit electronic or written
comments on the draft guidance by June 4, 2012. Submit electronic or
written comments on the proposed collection of information by June 4,
2012.

ADDRESSES: Submit written requests for single copies of the draft
guidance document entitled ``Modified Risk Tobacco Product
Applications'' to the Center for Tobacco Products, Food and Drug
Administration, 9200 Corporate Blvd., Rockville, MD 20850-3229. Send
one self-addressed adhesive label to assist that office in processing
your request or include a fax number to which the draft guidance may be
sent. See the SUPPLEMENTARY INFORMATION section for electronic access
to the draft guidance document.
    Submit electronic comments on the draft guidance, including
comments on the proposed collection of information, to http://www.regulations.gov. Submit written comments to the Division of Dockets
Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane,
rm. 1061, Rockville, MD 20852. Identify comments with the docket number
found in brackets in the heading of this document.

FOR FURTHER INFORMATION CONTACT:  With regard to the draft guidance:
Gail Schmerfeld or Kristin Davis, Center for Tobacco Products, 9200
Corporate Blvd., Rockville, MD 20850-3229, 1-877-287-1373,
<EMAIL_ADDRESS>or<EMAIL_ADDRESS>    With regard to the proposed collection of information: Daniel
Gittleson, Office of Information Management, Food and Drug
Administration, 1350 Piccard Dr., P150-400B, Rockville, MD 20850, 301-
796-5156<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION:

I. Background

    On June 22, 2009, the President signed the Family Smoking
Prevention and Tobacco Control Act (Pub. L. 111-31) (Tobacco Control
Act) into law. The Tobacco Control Act grants FDA authority to regulate
the manufacture, marketing, and distribution of tobacco products to
protect public health generally and to reduce tobacco use by minors.
Congress found that it is essential that, prior to marketing tobacco
products for use to reduce harm or the risk of tobacco-related disease
or to reduce exposure to harmful substances associated with tobacco
products, manufacturers be required to ``demonstrate that such products
* * * meet a series of rigorous criteria, and will benefit the health
of the population as a whole'' (section 2(36) of the Tobacco Control
Act). Thus, section 101 of the Tobacco Control Act added section 911
(21 U.S.C. 387k) to the FD&C Act to prohibit the introduction or
delivery for introduction into interstate commerce of any modified risk
tobacco product unless an order

issued by FDA pursuant to section 911(g) of the FD&C Act is effective
with respect to such product. A modified risk tobacco product is any
tobacco product that is sold or distributed for use to reduce harm or
the risk of tobacco-related disease associated with commercially
marketed tobacco products (section 911(b)(1) of the FD&C Act).
    Section 911(l)(1) of the FD&C Act directs FDA to issue regulations
or guidance (or any combination thereof) on the scientific evidence
required for assessment and ongoing review of modified risk tobacco
products. FDA is issuing this draft guidance in compliance with section
911(l)(1). When finalized, the draft guidance will provide industry
with information on who submits modified risk tobacco product
applications (MRTPAs), when to submit a MRTPA, what information section
911 of the FD&C Act requires applicants to submit in a MRTPA, what
scientific evidence FDA recommends applicants include in a MRTPA, what
information should be collected through postmarket surveillance and
studies, how to organize and submit the MRTPA, and FDA's timeframe for
review of a MRTPA. It will also provide for the filing of a single
application for any modified risk tobacco product that is also a new
tobacco product.
    Section 911(l)(2) of the FD&C Act directs FDA to consult with the
Institute of Medicine (IOM), and get the input of other appropriate
scientific and medical experts, on the design and conduct of studies
required for the assessment and ongoing review of modified risk tobacco
products. FDA gave IOM its charge on February 2, 2011. IOM published
its report on December 14, 2011. The report is available through http://www.iom.edu/Reports/2011/Scientific-Standards-for-Studies-on-Modified-Risk-Tobacco-Products.aspx and will be placed in the docket for this
draft guidance. In order to get input from other experts, FDA held a
public workshop on August 25 and 26, 2011, and established a docket,
FDA-2011-N-0443, to receive public comments. FDA intends to consider
the IOM report and comments submitted to the public workshop docket in
preparing the final guidance.

II. Significance of Guidance

    FDA is issuing this draft guidance document consistent with FDA's
good guidance practices regulation (21 CFR 10.115). The draft guidance,
when finalized, will represent the Agency's current thinking on
``Modified Risk Tobacco Product Applications.'' It does not create or
confer any rights for or on any person and does not operate to bind FDA
or the public. An alternative approach may be used if such approach
satisfies the requirements of the applicable statute and regulations.

III. Paperwork Reduction Act of 1995

    Under the Paperwork Reduction Act of 1995 (the PRA) (44 U.S.C.
3501-3520), Federal Agencies must obtain approval from the Office of
Management and Budget (OMB) for each collection of information they
conduct or sponsor. ``Collection of information'' is defined in 44
U.S.C. 3502(3) and 5 CFR 1320.3(c) and includes Agency requests or
requirements that members of the public submit reports, keep records,
or provide information to a third party. Section 3506(c)(2)(A) of the
PRA (44 U.S.C. 3506(c)(2)(A)) requires Federal Agencies to provide a
60-day notice in the Federal Register concerning each proposed
collection of information before submitting the collection to OMB for
approval. To comply with this requirement, FDA is publishing notice of
the proposed collection of information set forth in this document.
    With respect to the following collection of information, FDA
invites comments on these topics: (1) Whether the proposed collection
of information is necessary for the proper performance of FDA's
functions, including whether the information will have practical
utility; (2) the accuracy of FDA's estimate of the burden of the
proposed collection of information, including the validity of the
methodology and assumptions used; (3) ways to enhance the quality,
utility, and clarity of the information to be collected; and (4) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques, when
appropriate, and other forms of information technology.

Draft Guidance for Industry: Modified Risk Tobacco Product Applications
(OMB Control Number 0910-NEW)

    This draft guidance describes the information that the FD&C Act
requires you to submit in your MRTPA as well as FDA's recommendations
regarding the scientific evidence that should be contained in a MRTPA
for FDA to make an assessment and conduct an ongoing review of modified
risk tobacco products. The draft guidance also permits the filing of a
single application for any modified risk tobacco product that is also a
new tobacco product under section 910 of the FD&C Act. The draft
guidance document discusses, among other things: Who submits MRTPAs,
when to submit a MRTPA, what information section 911 of the FD&C Act
requires applicants to submit in a MRTPA, what scientific evidence FDA
recommends applicants include in a MRTPA, what information should be
collected through postmarket surveillance and studies, and how to
organize and submit a MRTPA. The purpose of the proposed information
collection is to allow FDA to collect statutorily mandated information
regarding modified risk tobacco products and other information that
will facilitate FDA's effective and efficient review of MRTPAs.
    Modified risk tobacco products are tobacco products that are sold
or distributed for use to reduce harm or the risk of tobacco-related
disease associated with commercially marketed tobacco products (section
911(b)(1) of the FD&C Act). No person may introduce or deliver for
introduction into interstate commerce any modified risk tobacco product
unless an order issued pursuant to section 911(g) of the FD&C Act is
effective with respect to that product (section 911(a) of the FD&C
Act).
    Under section 911(d) of the FD&C Act, a MRTPA must contain:
     A description of the proposed product and any proposed
advertising and labeling;
     The conditions for using the product;
     The formulation of the product;
     Sample product labels and labeling;
     All documents (including underlying scientific
information) relating to research findings conducted, supported, or
possessed by the tobacco product manufacturer relating to the effect of
the product on tobacco-related diseases and health-related conditions,
including information both favorable and unfavorable to the ability of
the product to reduce risk or exposure and relating to human health;
     Data and information on how consumers actually use the
tobacco product; and
     Such other information as the Secretary may require.
    Further, FDA's regulation implementing the National Environmental
Policy Act of 1969 requires that ``[a]ll applications or petitions
requesting agency action require the submission of an [environmental
assessment] or a claim of categorical exclusion'' (21 CFR 25.15(a)).
    Section 911(g) of the FD&C Act describes the demonstrations
applicants must make to obtain an order from FDA. Sections 911(g)(1)
and (2) of the FD&C Act set forth two bases for FDA to issue an order.

    A ``risk modification order'' is an order permitting the
introduction or delivery for introduction into interstate commerce of a
tobacco product that FDA has found meets the criteria for an order
under section 911(g)(1) of the FD&C Act. In order for FDA to issue a
risk modification order under section 911(g)(1) of the FD&C Act, the
applicant must demonstrate that the proposed modified risk tobacco
product, as it is actually used by consumers, will:
     Significantly reduce harm and the risk of tobacco-related
disease to individual tobacco users; and
     Benefit the health of the population as a whole taking
into account both users of tobacco products and persons who do not
currently use tobacco products.
    An ``exposure modification order'' is an order permitting the
introduction or delivery for introduction into interstate commerce of a
tobacco product that reduces or eliminates exposure to a substance and
for which the available scientific evidence suggests that a measurable
and substantial reduction in morbidity and mortality is likely to be
demonstrated in future studies. In order for FDA to issue an exposure
modification order, the applicant must satisfy all of the criteria for
issuance of an order under section 911(g)(2) of the FD&C Act.
    FDA may issue an exposure modification order under section
911(g)(2) of the FD&C Act (the ``special rule'') if it determines that
the applicant has demonstrated that:
     Such an order would be appropriate to promote the public
health;
     Any aspect of the label, labeling, and advertising for the
product that would cause the product to be a modified risk tobacco
product is limited to an explicit or implicit representation that the
tobacco product or its smoke does not contain or is free of a substance
or contains a reduced level of a substance, or presents a reduced
exposure to a substance in tobacco smoke;
     Scientific evidence is not available and, using the best
available scientific methods, cannot be made available without
conducting long-term epidemiological studies for an application to meet
the standards for obtaining an order under section 911(g)(1); and
     The scientific evidence that is available without
conducting long-term epidemiological studies demonstrates that a
measurable and substantial reduction in morbidity or mortality among
individual tobacco users is reasonably likely in subsequent studies
(section 911(g)(2)(A) of the FD&C Act).
    Furthermore, for FDA to issue an exposure modification order, FDA
must find that the applicant has demonstrated that:
     The magnitude of overall reductions in exposure to the
substance or substances, which are the subject of the application is
substantial, such substance or substances are harmful, and the product
as actually used exposes consumers to the specified reduced level of
the substance or substances;
     The product as actually used by consumers will not expose
them to higher levels of other harmful substances compared to the
similar types of tobacco products then on the market unless such
increases are minimal and the reasonably likely overall impact of use
of the product remains a substantial and measurable reduction in
overall morbidity and mortality among individual tobacco users;
     Testing of actual consumer perception shows that, as the
applicant proposes to label and market the product, consumers will not
be misled into believing that the product is or has been demonstrated
to be less harmful, or presents or has been demonstrated to present
less of a risk of disease than one or more other commercially marketed
tobacco products; and
     Issuance of the exposure modification order is expected to
benefit the health of the population as a whole taking into account
both users of tobacco products and persons who do not currently use
tobacco products (section 911(g)(2)(B) of the FD&C Act).
    In evaluating the benefit to health of individuals and of the
population as a whole under sections 911(g)(1) and (g)(2) of the FD&C
Act, FDA must take into account:
     The relative health risks the modified risk tobacco
product presents to individuals;
     The increased or decreased likelihood that existing
tobacco product users who would otherwise stop using such products will
switch to using the modified risk tobacco product;
     The increased or decreased likelihood that persons who do
not use tobacco products will start using the modified risk tobacco
product;
     The risks and benefits to persons from the use of the
modified risk tobacco product compared to the use of smoking cessation
drug or device products approved by FDA to treat nicotine dependence;
and
     Comments, data, and information submitted to FDA by
interested persons (section 911(g)(4) of the FD&C Act).
    Furthermore, FDA must ensure that the advertising and labeling of
the MRTP enable the public to comprehend the information concerning
modified risk and to understand the relative significance of such
information in the context of total health and in relation to all of
the tobacco-related diseases and health conditions (section 911(h)(1)
of the FD&C Act).
    FDA intends to determine whether it will issue an order under
section 911(g) within 360 days after the receipt of a complete
application and will issue such an order only if the application
satisfies all the applicable requirements in section 911.
    A risk modification order issued under section 911(g)(1) will be
effective for the period of time specified in the order issued by FDA
(section 911(h)(4) of the FD&C Act). An applicant to whom a risk
modification order is issued under section 911(g)(1) must conduct
postmarket surveillance and studies (section 911(i)(1) of the FD&C
Act).
    An exposure modification order issued under section 911(g)(2) will
be effective for a term of not more than 5 years. FDA may renew an
exposure modification order if the applicant files a new application,
and FDA finds that the requirements for such order under section
911(g)(2) continue to be satisfied (section 911(g)(2)(C)(i) of the FD&C
Act). Further, an exposure modification order will be conditioned on
the applicant's agreement to conduct postmarket surveillance and
studies and to submit the results of such surveillance and studies to
FDA annually (section 911(g)(2)(C)(ii) and (iii) of the FD&C Act).
    The postmarket surveillance and studies that all applicants who
receive orders are required to conduct are intended to determine the
effect of issuance of an order on consumer perception, behavior, and
health, and enable FDA to review the accuracy of the determinations
upon which an order was based (section 911(g)(2)(C)(ii) and (i)(1) of
the FD&C Act). An applicant who receives a risk modification order must
also conduct postmarket surveillance and studies that provide
information FDA determines is otherwise necessary regarding the use or
health risks involving the tobacco product (section 911(i)(1) of the
FD&C Act).
    If the proposed modified risk tobacco product is a new tobacco
product within the meaning of section 910(a)(1), the new tobacco
product must satisfy any applicable premarket review requirements under
section 910 of the FD&C Act, in addition to any requirements under
section 911 of the

FD&C Act. A new tobacco product must be found to be substantially
equivalent, exempt from the requirement to obtain a substantial
equivalence determination, or have a marketing authorization order
under section 910(c)(1)(A)(i). The collections of information relating
to premarket review described in the ``Guidance for Industry: Section
905(j) Reports: Demonstrating Substantial Evidence for Tobacco
Products'' (OMB control number 0910-0673), 21 CFR part 1107
(Establishment Registration, Product Listing, and Substantial
Equivalence Reports) (OMB control number 0910-0684), and ``Draft
Guidance for Industry: Applications for Premarket Review of New Tobacco
Products'' (OMB control number 0910-NEW) have been previously approved,
or are pending approval, by OMB. An applicant may file the appropriate
report or application to satisfy any applicable premarket review
requirements and a separate application under section 911. In the
alternative, the applicant may file a single application. The single
application must include the information required for the applicable
premarket review (i.e., substantial equivalence report, request of
exemption from substantial equivalence requirements, or the information
required for premarket review under section 910(b) of the FD&C Act), as
well as the information required to support issuance of an order under
section 911(g) of the FD&C Act. To the extent data or information
contained in the premarket review portion of the application is also
relevant to or required for the modified risk determination, the
applicant may cross-reference that data or information rather than
duplicate it in the modified risk portion of the application.
    Description of respondents: The respondents to this collection of
information are applicants who are responsible for creating and
submitting modified risk tobacco product applications and who wish to
obtain an FDA order to allow them to market their product. While it is
expected that many of the respondents will be manufacturers,
respondents could include importers, distributors, and retailers of
tobacco products.
    FDA estimates the burden of this collection of information as
follows:

                                 Table 1--Estimated Annual Reporting Burden \1\
----------------------------------------------------------------------------------------------------------------
                                                                                Average
      Information collected          Number of       Number of     Total annual     burden per     Total annual
          (section(s))              respondents    responses per     responses     response  (in       hours
                                                    respondent                        hours)
----------------------------------------------------------------------------------------------------------------
MRTPA (911(d) of FD&C Act)......               3               1               3          45,200         135,600
Environmental analysis (21 CFR                 3               1               3              10              30
 25.15).........................
Request for a meeting prior to                 8               1               8               8              64
 submitting a MRTPA.............
Submission of postmarket                       3               1               3              30              90
 surveillance and study
 protocols (911(g)(2)(C)(ii) and
 911(i)(2)).....................
Conduct of postmarket                          5               1               5          40,200         201,000
 surveillance and studies
 (911(g)(2)(C)(ii) and
 911(i)(1)).....................
Annual submission of results of                5               1               5             140             700
 postmarket surveillance and
 studies (911(g)(2)(C)(iii) and
 911(i)(1)).....................
Requests for renewal                           1               1               1             140             140
 (911(g)(2)(C)(i) and 911(h)(4))
                                 -------------------------------------------------------------------------------
    Total Reporting Burden Hours  ..............  ..............  ..............  ..............         337,624
----------------------------------------------------------------------------------------------------------------
\1\There are no capital costs or operating and maintenance costs associated with this collection of information.

    Table 1 describes the annual reporting burden as a result of
submitting a MRTPA. FDA estimates that it will receive 3 MRTPAs
annually and that it will take the applicant 200 hours to collect the
information necessary to submit a MRTPA under section 911 of the FD&C
Act. FDA estimates it will take the applicant an additional 45,000
hours to conduct studies needed to support its MRTPA. FDA is also
including an estimation of the burden associated with preparing
environmental analyses. FDA estimates that it will take an additional
10 hours to prepare any environmental analyses. FDA encourages persons
considering developing a MRTPA to meet with CTP to discuss MRTPA
submission and investigational requirements. FDA anticipates that eight
persons considering developing MRTPAs may request meetings with FDA.
FDA estimates it will take 8 hours to prepare a meeting request,
including background information.
    Section 911 of the FD&C Act requires applicants to whom FDA issues
orders to conduct postmarket surveillance and studies and submit
relevant information to FDA on an annual basis. Applicants must submit
and receive FDA approval of surveillance protocols. FDA estimates that
it will take 30 hours to collect and submit the protocol information to
FDA. FDA estimates it will take the applicant an additional 40,200
hours to conduct the postmarket surveillance and studies. FDA estimates
5 applicants will submit results of postmarket surveillance and studies
annually and it will take 140 hours to prepare each submission.
    Because orders issued under section 911(g) are valid for only a set
number of years, FDA expects applicants will submit requests for
renewal. Because the dates on which orders are issued and the length of
the period for which the order is valid will vary, FDA expects one
request for renewal annually. FDA estimates that it will take 140 hours
to prepare the request for renewal.
    The total number of hours for this collection of information is
estimated to be 337,624 ((3 x (45,200 + 10)) + (8 x 8) + (3 x 30) + (5
x 40,200) + (5 x 140) + (1 x 140)). These burden estimates were
computed using FDA staff expertise and by reviewing comments received
from recent FDA information collections for other tobacco-related
initiatives.

IV. Request for Comments

    FDA requests comments from interested parties on any of the topics
addressed in the draft guidance. In addition, as stated in the ``I.
Background'' section, FDA intends to consider the IOM report in
preparing the final guidance. Therefore, FDA requests comments from
interested parties on the IOM report, which was issued on December 14,
2011. FDA specifically requests comments on:
     IOM's Recommendation 2: ``The FDA should establish
guidance that conveys an expected sequencing of studies, such that
preclinical work is

completed and submitted to the FDA before clinical (human subjects)
work commences, and [FDA should establish] that there is a reasonable
expectation based on preclinical work that a reduction or lack of harm
will be seen in humans.'' Should FDA address expected sequencing of
studies in its guidance? If the Agency should, what guidance should the
Agency provide?; and
     IOM's Recommendation 10: ``MRTP sponsors should consider
use of independent third parties to undertake one or more key
functions, including the design and conduct of research, the oversight
of specific studies, and the distribution of sponsor funds for
research. Such independent third parties should be approved by the FDA
in advance of the research.'' Should FDA recommend such an approach in
its guidance? If the Agency should, what guidance should the Agency
provide?
    Interested persons may submit to the Division of Dockets Management
(see ADDRESSES) either electronic or written comments regarding this
document. It is only necessary to send one set of comments. Identify
comments with the docket number found in brackets in the heading of
this document. Received comments may be seen in the Division of Dockets
Management between 9 a.m. and 4 p.m., Monday through Friday.

V. Electronic Access

    Persons with access to the Internet may obtain an electronic
version of the draft guidance document at http://www.regulations.gov
and http://www.fda.gov/TobaccoProducts/GuidanceComplianceRegulatoryInformation/default.htm.

    Dated: March 28, 2012.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2012-7908 Filed 3-30-12; 11:15 am]
BILLING CODE 4160-01-P


[Federal Register Volume 79, Number 169 (Tuesday, September 2, 2014)]
[Notices]
[Page 52103]
[FR Doc No: 2014-20871]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration

Government/Industry Aeronautical Charting Forum Meeting

AGENCY: Federal Aviation Administration (FAA), DOT.

ACTION: Notice of public meeting.

-----------------------------------------------------------------------

SUMMARY: This notice announces the bi-annual meeting of the Federal
Aviation Administration (FAA) Aeronautical Charting Forum (ACF) to
discuss informational content and design of aeronautical charts and
related products, as well as instrument flight procedures development
policy and design criteria.

DATES: The ACF is separated into two distinct groups. The Instrument
Procedures Group (IPG) will meet October 28, 2014 from 8:30 a.m. to
5:00 p.m. The Charting Group will meet October 29 and 30, 2014 from
8:30 a.m. to 5:00 p.m.

ADDRESSES: The meeting will be hosted by Innovative Solutions
International, a Pragmatics, Inc. Company at 1761 Business Center
Drive, Reston, VA 20190.

FOR FURTHER INFORMATION CONTACT: For information relating to the
Instrument Procedures Group, contact Thomas E. Schneider, FAA, Flight
Procedures Standards Branch, AFS-420, 6500 South MacArthur Blvd., P.O.
Box 25082, Oklahoma City, OK 73125; telephone:<PHONE_NUMBER>.
    For information relating to the Charting Group, contact Valerie S.
Watson, FAA, National Aeronautical Navigation Products (AeroNav
Products), Quality Assurance & Regulatory Support, AJV-3, 1305 East-
West Highway, SSMC4, Station 3409, Silver Spring, MD 20910; telephone:
(301) 427-5155.

SUPPLEMENTARY INFORMATION: Pursuant to Sec.  10(a)(2) of the Federal
Advisory Committee Act (Pub. L. 92-463; 5 U.S.C. App. II), notice is
hereby given of a meeting of the FAA Aeronautical Charting Forum to be
held from October 28 through October 30, 2014, from 8:30 a.m. to 5:00
p.m. at Innovative Solutions International (ISI), a Pragmatics Inc.
Company, at their offices at 1761 Business Center Drive, Reston, VA
20190.
    The Instrument Procedures Group agenda will include briefings and
discussions on recommendations regarding pilot procedures for
instrument flight, as well as criteria, design, and developmental
policy for instrument approach and departure procedures.
    The Charting Group agenda will include briefings and discussions on
recommendations regarding aeronautical charting specifications, flight
information products, and new aeronautical charting and air traffic
control initiatives. Attendance is open to the interested public, but
will be limited to the space available.
    Please note the following special security requirements for access
to the Pragmatics, Inc. Corporation Headquarters. A picture I.D. is
required of all US citizens. All foreign national participants are
required to have a passport. Additionally, not later than October 3,
2014, foreign national attendees must provide their name, country of
citizenship, company/organization representing, and country of the
company/organization. Send the information to: Steve VanCamp,
Pragmatics Inc., FAA, Aviation Safety--Flight Standards Service, AFS-
420, 6500 South MacArthur Blvd., P.O. Box 25082, Oklahoma City, OK,
73125 or via Email (preferred) to<EMAIL_ADDRESS>Foreign
nationals who do not provide the required information will not be
allowed entrance--NO EXCEPTIONS.
    The public must make arrangements by October 7, 2014, to present
oral statements at the meeting. The public may present written
statements and/or new agenda items to the committee by providing a copy
to the person listed in the FOR FURTHER INFORMATION CONTACT section not
later than October 7, 2014. Public statements will only be considered
if time permits.

    Issued in Washington, DC, on August 25, 2014.
Valerie S. Watson,
Co-Chair, Aeronautical Charting Forum.
[FR Doc. 2014-20871 Filed 8-29-14; 8:45 am]
BILLING CODE 4910-13-P


[Federal Register Volume 80, Number 20 (Friday, January 30, 2015)]
[Notices]
[Page 5194]
[FR Doc No: 2015-01833]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration

Fourth Meeting: RTCA Special Committee 229, 406 MHz Emergency
Locator Transmitters (ELTs) Joint With EUROCAE WG-98 Committee

AGENCY: Federal Aviation Administration (FAA), U.S. Department of
Transportation (DOT).

ACTION: Fourth meeting 406 MHz Emergency Locator Transmitters (ELTs)
Joint with EUROCAE WG-98 Committee.

-----------------------------------------------------------------------

SUMMARY: The FAA is issuing this notice to advise the public of the
fourth meeting of the 406 MHz Emergency Locator Transmitters (ELTs)
Joint with EUROCAE WG-98 Committee.

DATES: The meeting will be held April 21-23 2015 from 9:00 a.m.-5:00
p.m.

ADDRESSES: The meeting will be held AIRBUS, Kreetslag 10, 21129
Hamburg, Germany.

FOR FURTHER INFORMATION CONTACT: The RTCA Secretariat, 1150 18th Street
NW., Suite 910, Washington, DC 20036, or by telephone at (202) 833-
9339, fax at<PHONE_NUMBER>, or Web site at http://www.rtca.org or you
may contact Sophie Bousquet<EMAIL_ADDRESS>202-330-0663.

SUPPLEMENTARY INFORMATION: Pursuant to section 10(a)(2) of the Federal
Advisory Committee Act (Pub. L. 92-463, 5 U.S.C., App.), notice is
hereby given for a meeting of Special Committee 224. The agenda will
include the following:

Tuesday April 21 2015 (9:30 a.m.-5:00 p.m.)

 Welcome/Introductions/Administrative Remarks
 Agenda overview and approval
 Minutes Washington, DC meeting review and approval
 Briefing of ICAO and COSPAS-SARSAT activities
 WG 1 to 4 status and week's plan
 Other Industry coordination and presentations
 WG meetings (rest of the day)

Wednesday April 22nd 2015 (9 a.m.-5 p.m.)

 WG 1 to 4 meetings

Thursday April 23rd 2015

 WGs' reports
 Action item review
 Future meeting plans and dates
 Industry coordination and presentations (if any)
 Other business
 Adjourn

    Attendance is open to the interested public but limited to space
availability. With the approval of the chairman, members of the public
may present oral statements at the meeting. Persons wishing to present
statements or obtain information should contact the person listed in
the FOR FURTHER INFORMATION CONTACT section. Members of the public may
present a written statement to the committee at any time.

    Issued in Washington, DC, on January 27, 2015.
Mohannad Dawoud,
Management Analyst, NextGen, Program Oversight and Administration,
Federal Aviation Administration.
[FR Doc. 2015-01833 Filed 1-29-15; 8:45 am]
BILLING CODE 4910-13-P


[Federal Register Volume 77, Number 68 (Monday, April 9, 2012)]
[Notices]
[Pages 21120-21122]
[FR Doc No: 2012-8428]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[Release No. 34-66725; File No. SR-NYSEArca-2012-26]

Self-Regulatory Organizations; NYSE Arca, Inc.; Notice of Filing
of Proposed Rule Change to List and Trade Option Contracts Overlying 10
Shares of a Security (``Mini-Options Contracts'') and Implementing Rule
Text Necessary to Distinguish Mini-Options Contracts From Option
Contracts Overlying 100 Shares of a Security (``Standard Contracts'')

April 3, 2012.
    Pursuant to Section 19(b)(1) of the Securities Exchange Act of 1934
(the ``Act'') \1\ and Rule 19b-4 thereunder,\2\ notice is hereby given
that on March 23, 2012, NYSE Arca, Inc. (the ``Exchange'' or ``NYSE
Arca'') filed with the Securities and Exchange Commission (the
``Commission'') the proposed rule change as described in Items I and II
below, which Items have been prepared by the self-regulatory
organization. The Commission is publishing this notice to solicit
comments on the proposed rule change from interested persons.
---------------------------------------------------------------------------

    \1\ 15 U.S.C. 78s(b)(1).
    \2\ 17 CFR 240.19b-4.
---------------------------------------------------------------------------

I. Self-Regulatory Organization's Statement of the Terms of Substance
of the Proposed Rule Change

    The Exchange proposes to list and trade option contracts overlying
10 shares of a security (``mini-options contracts'') and implement rule
text necessary to distinguish mini-options contracts from option
contracts overlying 100 shares of a security (``standard contracts'').
The text of the proposed rule change is available at the Exchange,
www.nyse.com, and the Commission's Public Reference Room.

II. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change

    In its filing with the Commission, the self-regulatory organization
included statements concerning the purpose of, and basis for, the
proposed rule change and discussed any comments it received on the
proposed rule change. The text of those statements may be examined at
the places specified in Item IV below. The Exchange has prepared
summaries, set forth in sections A, B, and C below, of the most
significant parts of such statements.

A. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change

1. Purpose
    The Exchange is proposing to list and trade mini-options contracts
and implement rule text necessary to distinguish mini-options contracts
from standard contracts. Whereas standard contracts represent a
deliverable of 100 shares of an underlying security, mini-options
contracts would represent a deliverable of 10 shares. The Exchange
proposes to list and trade mini-options contracts overlying 5 high
priced securities for which the standard contract overlying the same
security exhibits significant liquidity.\3\ The Exchange believes that
investors would benefit from the availability of mini-options contracts
by making options overlying high priced securities more readily
available as an investing tool and at more affordable and realistic
prices, most notably for the average retail investor.
---------------------------------------------------------------------------

    \3\ The Exchange proposes that mini-options contracts would be
listed in only five issues, specifically SPDR S&P 500 (SPY), Apple,
Inc. (AAPL), SPDR Gold Trust (GLD), Google Inc. (GOOG), and
Amazon.com Inc. (AMZN). These issues were selected because they are
priced greater than $100 and are among the most actively traded
issues, in that the standard contract exhibits average daily volume
(``ADV'') over the previous three calendar months of at least 45,000
contracts, excluding LEAPS and FLEX series. The Exchange notes that
any expansion of the program would require that a subsequent
proposed rule change be submitted with the Commission.
---------------------------------------------------------------------------

    For example, with Apple Inc. (``AAPL'') trading at $605.85 on March
21, 2012, ($60,585 for 100 shares underlying a standard contract), the
605 level call expiring on March 23 is trading at $7.65. The cost of
the standard contract overlying 100 shares would be $765, which is
substantially higher in notional terms than the average equity option
price of $250.89.\4\ Proportionately equivalent mini-options contracts
on AAPL would provide investors with the ability to manage and hedge
their portfolio risk on their underlying investment, at a price of $76
per contract. In addition, investors who hold a position in AAPL at
less than the round lot size would still be able to avail themselves of
options to manage their portfolio risk. For example, the holder of 50
shares of AAPL could write covered calls for five mini-options
contracts. The table below demonstrates the proposed differences
between a mini-options contracts and a standard contract with a strike
price of $125 per share and a bid or offer of $3.20 per share:
---------------------------------------------------------------------------

    \4\ A high priced underlying security may have relatively
expensive options, because a low percentage move in the share price
may mean a large movement in the options in terms of absolute
dollars. Average non-FLEX equity option premium per contract January
1-December 31, 2011. See http://www.theocc.com/webapps/monthly-volume-reports?reportClass=equity.

------------------------------------------------------------------------
                                     Standard               Mini
------------------------------------------------------------------------
Share Deliverable Upon          100 shares.......  10 shares
 Exercise.
Strike Price..................  125..............  12.5

Bid/Offer.....................  3.20.............  .32
Premium Multiplier............  100..............  100
    Total Value of Deliverable  12,500...........  1,250
    Total Value of Contract...  320..............  32
------------------------------------------------------------------------

    The Exchange notes that the Commission has approved an earlier
proposal of NYSE Arca to list and trade option contracts overlying a
number of shares other than 100.\5\ Moreover, the concept of listing
and trading parallel options products of reduced values and sizes on
the same underlying security is not novel. For example, parallel
product pairs on a full-value and reduced-value basis are currently
listed on the S&P 500 Index (``SPX'' and ``XSP,'' respectively), the
Nasdaq 100 Index (``NDX'' and ``MNX,'' respectively) and the Russell
2000 Index (``RUT'' and ``RMN,'' respectively).
---------------------------------------------------------------------------

    \5\ See Securities Exchange Act Release No. 44025 (February 28,
2001) 66 FR 13986 (March 8, 2001) (approving SR-PCX-01-12).
---------------------------------------------------------------------------

    The Exchange believes that the proposal to list and trade mini-
options contracts would not lead to investor confusion. On the
contrary, the Exchange's proposal is structured to easily convey strike
prices and premiums to investors in the total amount of the investment
(100 times the displayed premium) and the amount of the deliverable
(100 times the strike price). The Exchange believes that the difference
between the price of the 100 share standard contract and the 10 share
mini-options contract would immediately alert investors that the
contract is different, thereby avoiding inadvertent investment in the
wrong contract. Additionally, the Exchange will designate mini-options
contracts with a different trading symbols than their related standard
contract.\6\ The Exchange believes that the clarity of this approach is
appropriate and transparent, as supported by the recent Options
Clearing Corporation (``OCC'') filing to amend its bylaws to
accommodate such strike prices and premiums.\7\ Moreover, the Exchange
believes that the terms of mini-options contracts are consistent with
the terms of the Options Disclosure Document.
---------------------------------------------------------------------------

    \6\ OCC Symbology is structured for contracts with other than
100 shares to be designated with a numerical suffix to the standard
trading symbol, i.e., AAPL8.
    \7\ See Securities Exchange Act Release No. 61485 (February 3,
2010), 75 FR 6750 (February 10, 2010) (SR-OCC-2010-01).
---------------------------------------------------------------------------

    The Exchange recognizes the need to differentiate mini-options
contracts from standard options and therefore is proposing the
following changes to its rules.
    The Exchange proposes to add Commentary .01 to Rule 6.3 (Option
Contracts to Be Traded) to reflect that, in addition to option
contracts with a unit of trading of 100, the Exchange may list option
contracts overlying 10 shares of SPDR S&P 500 (SPY), Apple, Inc.
(AAPL), SPDR Gold Trust (GLD), Google Inc. (GOOG), and Amazon.com Inc.
(AMZN) for all expirations applicable to 100 share options in each
class. The Exchange believes that these five securities are appropriate
because they are high priced securities for which there is already
significant options liquidity and therefore significant customer
demand.
    The Exchange also proposes to add Commentary .14 to Rule 6.4
(Series of Options Open for Trading) to list series of mini-options
provided that (i) the underlying security has been designated as
eligible under Rule 6.3 Commentary .01, (ii) no mini-options series
will be listed with a strike price less than $10, and (iii) for each
mini-options contract there is a corresponding option contract with a
unit of trading of 100 overlying the same security, and that the
underlying security is trading over $90 to list additional mini-options
series. Commentary .14 would also delineate that strike prices for
contracts overlying 10 shares shall be set at 1/100th of the value of
the contract deliverable value. For example, an option contract to
deliver 10 shares of stock at $125 per share has a total deliverable
value of $1,250, and the strike price would be set at 12.50. The
Exchange notes that this is consistent with the current determination
of strike prices for standard contracts as well as options on the full
and reduced-values of the indexes referenced above. Additionally, by
restricting mini-options series to a strike price of $10 or greater and
to a corresponding standard strike overlying 100 shares, the Exchange
will limit the number of series and also maintain its application to
high priced underlyings. Also, the Exchange proposes to not permit the
listing of additional mini-options series if the underlying is trading
at $90 or less to limit the number of strikes once the underlying is no
longer a high priced security. The Exchange proposes a $90.01 minimum
for continued qualification so that additional mini-options that
correspond to standard strikes may be added even though the underlying
has fallen slightly below the initial qualification standard. In
addition, the underlying security must be trading above $90 for five
consecutive days before the listing of mini-option contracts in a new
expiration month. This restriction will allow the Exchange to list
mini-option strikes without disruption when a new expiration month is
added even if the underlying has had a minor decline in price.
    The Exchange also proposes to add Commentary .08 to Rule 6.8
(Position Limits) to reflect that, for purposes of compliance with the
Position Limits of Rules 6.8, ten mini-options contracts will equal one
standard contract overlying 100 shares.
    The Exchange also proposes to add subsection (c) to Rule 6.71
(Meaning of Premium Bids and Offers) to extend the explanation of bids
and offers with respect to mini-options contracts and also remove
references to Exchange-Traded Fund Shares, because other types of
underlying securities have options traded on them.
    Finally, the Exchange proposes to add Commentary .03 to Rule 6.72,
Trading Differentials, to allow quoting in penny increments in mini-
options contracts, because a penny increment in a mini-option is
equivalent to quoting at an increment of $0.10 per share.
    With regard to the impact of this proposal on system capacity, the
Exchange has analyzed its capacity and represents that it and the
Options Price Reporting Authority have the necessary systems capacity
to handle the potential additional traffic associated with the listing
and trading of mini-options contracts. The Exchange has further
discussed the proposed listing and trading of mini-options contracts
with the OCC, which has represented that it is able to accommodate the
proposal.
2. Statutory Basis
    The Exchange believes the proposed rule change is consistent with
Section 6(b) \8\ of the Securities Exchange Act of 1934 (the ``Act''),
in general, and furthers the objectives of Section

6(b)(5),\9\ in particular, because it is designed to promote just and
equitable principles of trade, to prevent fraudulent and manipulative
acts, to remove impediments to and to perfect the mechanism for a free
and open market and a national market system and, in general, to
protect investors and the public interest. Specifically, the Exchange
believes that investors would benefit from the availability of mini-
options contracts by making options on high priced securities more
readily available as an investing tool and at more affordable and
realistic prices, most notably for the average retail investor. As
described above, the proposal contains a number of features designed to
protect investors by reducing investor confusion, such as the mini-
options contracts being designated by different trading symbols from
their related standard contracts.\10\ Moreover, the proposal is
designed to protect investors and the public interest by providing
investors with an enhanced tool to reduce risk in high priced
securities. In particular, the proposed contracts will provide retail
customers who invest in high priced issues in lots of less than 100
shares with a means of protecting their investments that is presently
only available to those who have positions of 100 shares or more.
Further, the proposal currently is limited to five high priced
securities for which there is already significant options liquidity,
and therefore significant customer demand and trading volume.
---------------------------------------------------------------------------

    \8\ 15 U.S.C. 78f(b).
    \9\ 15 U.S.C. 78f(b)(5).
    \10\ See supra note 6.
---------------------------------------------------------------------------

B. Self-Regulatory Organization's Statement on Burden on Competition

    The Exchange does not believe that the proposed rule change will
impose any burden on competition that is not necessary or appropriate
in furtherance of the purposes of the Act.

C. Self-Regulatory Organization's Statement on Comments on the Proposed
Rule Change Received From Members, Participants or Others

    No written comments were solicited or received with respect to the
proposed rule change.

III. Date of Effectiveness of the Proposed Rule Change and Timing for
Commission Action

    Within 45 days of the date of publication of this notice in the
Federal Register or within such longer period (i) as the Commission may
designate up to 90 days of such date if it finds such longer period to
be appropriate and publishes its reasons for so finding or (ii) as to
which the self-regulatory organization consents, the Commission will:
    (A) By order approve or disapprove the proposed rule change, or
    (B) Institute proceedings to determine whether the proposed rule
change should be disapproved.

IV. Solicitation of Comments

    Interested persons are invited to submit written data, views, and
arguments concerning the foregoing, including whether the proposed rule
change is consistent with the Act. Comments may be submitted by any of
the following methods:

Electronic Comments

     Use the Commission's Internet comment form (http://www.sec.gov/rules/sro.shtml); or
     Send an email to<EMAIL_ADDRESS>Please include
File No. SR-NYSEArca-2012-26 on the subject line.

Paper Comments

     Send paper comments in triplicate to Elizabeth M. Murphy,
Secretary, Securities and Exchange Commission, Station Place, 100 F
Street NE., Washington, DC 20549-1090.

All submissions should refer to File Number SR-NYSEArca-2012-26. This
file number should be included on the subject line if email is used. To
help the Commission process and review your comments more efficiently,
please use only one method. The Commission will post all comments on
the Commission's Internet Web site (http://www.sec.gov/rules/sro.shtml). Copies of the submission, all subsequent amendments, all
written statements with respect to the proposed rule change that are
filed with the Commission, and all written communications relating to
the proposed rule change between the Commission and any person, other
than those that may be withheld from the public in accordance with the
provisions of 5 U.S.C. 552, will be available for Web site viewing and
printing in the Commission's Public Reference Room, 100 F Street NE.,
Washington, DC 20549, on official business days between the hours of 10
a.m. and 3 p.m. Copies of such filing also will be available for
inspection and copying at the principal office of the Exchange. All
comments received will be posted without change; the Commission does
not edit personal identifying information from submissions. You should
submit only information that you wish to make available publicly. All
submissions should refer to File Number SR-NYSEArca-2012-26 and should
be submitted on or before April 30, 2012.
---------------------------------------------------------------------------

    \11\ 17 CFR 200.30-3(a)(12).

    For the Commission, by the Division of Trading and Markets,
pursuant to delegated authority.\11\
Elizabeth M. Murphy,
Secretary.
[FR Doc. 2012-8428 Filed 4-6-12; 8:45 am]
BILLING CODE 8011-01-P


[Federal Register Volume 86, Number 89 (Tuesday, May 11, 2021)]
[Notices]
[Pages 25854-25855]
[FR Doc No: 2021-09934]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

Combined Notice of Filings #2

    Take notice that the Commission received the following electric
rate filings:

    Docket Numbers: ER10-1989-018; ER10-2078-022; ER11-4678-018; ER12-
1660-021; ER12-631-019; ER13-2458-016; ER13-2474-019; ER15-1016-011;
ER16-1277-011; ER16-1293-011; ER17-2270-013; ER17-582-009; ER17-583-
009; ER18-2032-009; ER18-2091-008; ER19-2382-005; ER19-2495-005; ER19-
2513-005; ER19-774-007; ER20-2069-002; ER20-2070-003; ER20-2237-003;
ER20-2597-003; ER20-2603-003; ER20-637-003; ER20-780-003; ER21-255-004;
ER21-744-001.
    Applicants: Sky River LLC, White Oak Energy LLC, Vasco Winds, LLC,
Windpower Partners 1993, Tuscola Bay Wind, LLC, Tuscola Wind II, LLC,
Steele Flats Wind Project, LLC, Shafter Solar, LLC, White Pine Solar,
LLC, White Oak Solar, LLC, Westside Solar, LLC, Whitney Point Solar,
LLC, Stuttgart Solar, LLC, Wildcat Ranch Wind Project, LLC, Titan
Solar, LLC, Stanton Clean Energy, LLC, Story County Wind, LLC,
Wessington Springs Wind, LLC, Wilton Wind Energy II, LLC, Wilton Wind
Energy I, LLC, Sooner Wind, LLC, Wheatridge Wind Energy, LLC,
Wheatridge Wind II, LLC, Weatherford Wind, LLC, Soldier Creek Wind,
LLC, Skeleton Creek Wind, LLC, Taylor Creek Solar, LLC, Wallingford
Renewable Energy LLC.
    Description: Notice of Change in Status of GridLiance Transcos
(Part 4).
    Filed Date: 4/30/21.
    Accession Number: 20210430-5751.
    Comments Due: 5 p.m. ET 5/21/21.

    Docket Numbers: ER18-1535-007; ER10-1951-033; ER10-1970-021; ER10-
1972-021; ER10-1973-015; ER10-1974-026; ER10-2641-039; ER11-2192-017;
ER11-4462-054; ER11-4677-018; ER12-2444-017; ER12-676-014; ER13-2461-
016; ER14-21-009; ER14-2708-021; ER14-2709-020; ER14-2710-020; ER15-
2243-009; ER15-30-018; ER15-58-018; ER16-1440-014; ER16-1913-008; ER16-
2240-014; ER16-2241-013; ER16-2297-013; ER16-2443-008; ER16-2506-013;
ER17-1774-006; ER17-196-006; ER17-838-029; ER18-1981-009; ER18-2224-
012; ER18-2314-005; ER18-772-006; ER18-807-007; ER19-11-006; ER19-1128-
003; ER19-2266-004; ER20-1219-003; ER20-1220-003; ER20-1879-004; ER20-
1985-003; ER20-1988-004; ER20-1991-003; ER20-2012-003; ER20-2153-004;
ER20-2380-003; ER20-2648-003; ER20-792-003; ER21-183-001.
    Applicants: Montauk Energy Storage Center, LLC, Mountain View
Solar, LLC, NEPM II, LLC, New Mexico Wind, LLC, NextEra Blythe Solar
Energy Center, LLC, NextEra Energy Bluff Point, LLC, NextEra Energy
Duane Arnold, LLC, NextEra Energy Montezuma II Wind, LLC, NextEra
Energy Point Beach, LLC, NextEra Energy Marketing, LLC, NextEra Energy
Seabrook, LLC, NextEra Energy Services Massachusetts, LLC, Northeast
Energy Associates, A Limited Partnership, Ninnescah Wind Energy, LLC,
North Sky River Energy, LLC, Northern Colorado Wind Energy Center II,
LLC, Northern Colorado Wind Energy Center, LLC, Northern Divide Wind,
LLC, Nutmeg Solar, LLC, Oklahoma Wind, LLC, Oleander Power Project,
Limited Partnership, Oliver Wind Energy Center II, LLC, Oliver Wind I,
LLC, Oliver Wind III, LLC, Orbit Bloom Energy, LLC, Osborn Wind Energy,
LLC, Palo Duro Wind Energy, LLC, Palo Duro Wind Interconnection
Services, LLC, Peetz Logan Interconnect, LLC, Peetz Table Wind, LLC,
Pegasus Wind, LLC, Perrin Ranch Wind, LLC, Pheasant Run Wind, LLC, Pima
Energy Storage System, LLC, Pinal Central Energy Center, LLC, Ponderosa
Wind, LLC, Pratt Wind, LLC, Quitman Solar, LLC, Red Mesa Wind, LLC,
River Bend Solar, LLC, Roswell Solar, LLC, Rush Springs Energy Storage,
LLC, Rush Springs Wind Energy, LLC, Saint Solar, LLC, Sanford Airport
Solar, LLC, Seiling Wind, LLC, Seiling Wind II, LLC, Seiling Wind
Interconnection Services, LLC, Sholes Wind, LLC, Silver State Solar
Power South, LLC.
    Description: Notice of Change in Status of GridLiance Transcos
(Part 3).
    Filed Date: 4/30/21.
    Accession Number: 20210430-5754.
    Comments Due: 5 p.m. ET 5/21/21.

    Docket Numbers: ER19-2462-002; ER18-2264-007; ER19-289-005; ER11-
4111-002.
    Applicants: Macquarie Energy LLC, Macquarie Energy Trading LLC,
Cleco Cajun LLC, Hudson Ranch Power I LLC.
    Description: Supplement to November 30, 2020, February 2, 2021, and
March 1, 2021 Notice of Non-Material Change in Status of Macquarie
Energy LLC, et al.
    Filed Date: 5/4/21.
    Accession Number: 20210504-5184.
    Comments Due: 5 p.m. ET 5/25/21.

    Docket Numbers: ER20-1150-002.
    Applicants: The Dayton Power and Light Company, PJM
Interconnection, L.L.C.
    Description: Compliance filing: Dayton submits Compliance Filing
re: Refund Report in ER20-1150-001 to be effective 5/3/2020.
    Filed Date: 5/5/21.
    Accession Number: 20210505-5129.
    Comments Due: 5 p.m. ET 5/26/21.

    Docket Numbers: ER21-1225-001.
    Applicants: Long Ridge Energy Generation LLC.
    Description: Tariff Amendment: Deficiency Response to MBR
Application-Docket ER21-1225 to be effective 4/29/2021.
    Filed Date: 5/5/21.

    Accession Number: 20210505-5108.
    Comments Due: 5 p.m. ET 5/26/21.

    Docket Numbers: ER21-1832-000.
    Applicants: SunEnergy1, LLC.
    Description: Petition for Limited Waiver and Request for Shortened
Comment Period and Expedited Commission Approval of SunEnergy1, LLC.
    Filed Date: 5/3/21.
    Accession Number: 20210503-5144.
    Comments Due: 5 p.m. ET 5/24/21.

    The filings are accessible in the Commission's eLibrary system
(https://elibrary.ferc.gov/idmws/search/fercgensearch.asp) by querying
the docket number.
    Any person desiring to intervene or protest in any of the above
proceedings must file in accordance with Rules 211 and 214 of the
Commission's Regulations (18 CFR 385.211 and 385.214) on or before 5:00
p.m. Eastern time on the specified comment date. Protests may be
considered, but intervention is necessary to become a party to the
proceeding.
    eFiling is encouraged. More detailed information relating to filing
requirements, interventions, protests, service, and qualifying
facilities filings can be found at: http://www.ferc.gov/docs-filing/efiling/filing-req.pdf. For other information, call<PHONE_NUMBER>
(toll free). For TTY, call<PHONE_NUMBER>.

    Dated: May 5, 2021.
Kimberly D. Bose,
Secretary.
[FR Doc. 2021-09934 Filed 5-10-21; 8:45 am]
BILLING CODE 6717-01-P


[Federal Register Volume 77, Number 250 (Monday, December 31, 2012)]
[Notices]
[Pages 77072-77073]
[FR Doc No: 2012-31368]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

Combined Notice of Filings 1

    Take notice that the Commission received the following electric
corporate filings:
    Docket Numbers: EC13-52-000.
    Applicants: JPM Capital Corporation.
    Description: Section 203 Application of JPM Capital Corporation
Requesting Expedited Order and Confidential Treatment.
    Filed Date: 12/19/12.
    Accession Number: 20121219-5265.
    Comments Due: 5 p.m. ET 1/9/13.
    Take notice that the Commission received the following electric
rate filings:
    Docket Numbers: ER10-1790-009; ER12-1400-002; ER10-2595-002.
    Applicants: BP Energy Company, Flat Ridge 2 Wind Energy LLC, Flat
Ridge Wind Energy, LLC.
    Description: Updated Market Power Analysis for Southwest Power Pool
Region of BP Energy Company, et. al.
    Filed Date: 12/19/12.
    Accession Number: 20121219-5266.
    Comments Due: 5 p.m. ET 1/9/13.

    Docket Numbers: ER12-2669-002.
    Applicants: California Independent System Operator Corporation.
    Description: 2012-12-19 Replacement Requirement for RA Maintenance
Outages Compliance to be effective 11/20/2012.
    Filed Date: 12/20/12.
    Accession Number: 20121220-5100.
    Comments Due: 5 p.m. ET 1/10/13.

    Docket Numbers: ER13-81-002.
    Applicants: Frontier Utilities New York LLC.
    Description: Revised transmittal Letter to be effective 10/12/2012.
    Filed Date: 12/20/12.
    Accession Number: 20121220-5055.
    Comments Due: 5 p.m. ET 1/10/13.

    Docket Numbers: ER13-586-000.
    Applicants: California Independent System Operator Corporation.
    Description: 2012-12-19 Second Amendment to Valley Electric
Transition Agreement to be effective 2/19/2013.
    Filed Date: 12/19/12.
    Accession Number: 20121219-5135.
    Comments Due: 5 p.m. ET 1/9/13.

    Docket Numbers: ER13-587-000.
    Applicants: Carson Cogeneration Company LP.
    Description: Application for Order Accepting Initial Market-Based
Rate Tariff to be effective 2/1/2013.
    Filed Date: 12/19/12.
    Accession Number: 20121219-5161.
    Comments Due: 5 p.m. ET 1/9/13.

    Docket Numbers: ER13-588-000.
    Applicants: New York Independent System Operator, Inc.
    Description: NYISO Proposed Tariff Revisions Regarding
Interconnection Process Improvements to be effective 2/18/2013.
    Filed Date: 12/19/12.
    Accession Number: 20121219-5171.
    Comments Due: 5 p.m. ET 1/9/13.

    Docket Numbers: ER13-589-000.
    Applicants: Commonwealth Edison Company, PJM Interconnection,
L.L.C.
    Description: ComEd and Ameren submit PJM Service Agreement No. 3421
to be effective 12/20/2012.
    Filed Date: 12/19/12.
    Accession Number: 20121219-5181.
    Comments Due: 5 p.m. ET 1/9/13.

    Docket Numbers: ER13-590-000.
    Applicants: Southern California Edison Company.
    Description: LGIA with Sky River and Amended LGIA with North Sky
River Energy to be effective 12/12/2012.
    Filed Date: 12/20/12.
    Accession Number: 20121220-5000.
    Comments Due: 5 p.m. ET 1/10/13.

    Docket Numbers: ER13-591-000.
    Applicants: Louisville Gas and Electric Company.
    Description: OATT ATT M LGIA Rev Sec 5 17 2 to be effective 12/21/
2012.
    Filed Date: 12/20/12.
    Accession Number: 20121220-5056.
    Comments Due: 5 p.m. ET 1/10/13.

    Docket Numbers: ER13-592-000.
    Applicants: Wisconsin Public Service Corporation.
    Description: WPSC Distribution Interconnection Agreement with WEPCO
to be effective 1/1/2013.
    Filed Date: 12/20/12.
    Accession Number: 20121220-5098.
    Comments Due: 5 p.m. ET 1/10/13.

    The filings are accessible in the Commission's eLibrary system by
clicking on the links or querying the docket number.
    Any person desiring to intervene or protest in any of the above
proceedings must file in accordance with Rules 211 and 214 of the
Commission's Regulations (18 CFR 385.211 and 385.214) on or before 5:00
p.m. Eastern time on the specified comment date. Protests may be
considered, but intervention is necessary to become a party to the
proceeding.

    eFiling is encouraged. More detailed information relating to filing
requirements, interventions, protests, service, and qualifying
facilities filings can be found at: http://www.ferc.gov/docs-filing/efiling/filing-req.pdf. For other information, call<PHONE_NUMBER>
(toll free). For TTY, call<PHONE_NUMBER>.

    Dated: December 20, 2012.
Nathaniel J. Davis, Sr.,
Deputy Secretary.
[FR Doc. 2012-31368 Filed 12-28-12; 8:45 am]
BILLING CODE 6717-01-P